The technology transfer has a high priority and the MediGate GmbH supports the UKE as the central technology transfer office. The patent and exploitation strategy MediGate particularly targets out on the implementation of appropriate research results into products for the benefit of patients and to spin-off activities from the UKE. The researchers at the UKE may have recourse to the services of MediGate, eg contract management:

• for research and cooperation agreements
• assistance in registering patents: patent examination on relevance, market potential analysis, accompanied by the patent protection process,
• the exploitation of patents (assistance with sales of intellectual property rights, licensing, cooperation with business partners, spin-off) and
• the commercialization of patent-protected inventions